Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,982
archived clinical trials in
Endocrine

Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Clinical Research Center Meharry Medical College
mi
from
Nashville, TN
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Clinical Research Center Meharry Medical College
mi
from
Nashville, TN
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Texas Heart and Vascular Research
mi
from
Austin, TX
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Texas Heart and Vascular Research
mi
from
Austin, TX
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Southeast TX Clinical Research Center
mi
from
Beaumont, TX
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Southeast TX Clinical Research Center
mi
from
Beaumont, TX
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Cornerstone Family Medicine
mi
from
Big Spring, TX
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Cornerstone Family Medicine
mi
from
Big Spring, TX
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Texas Health Physicians Group
mi
from
Carrollton, TX
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Texas Health Physicians Group
mi
from
Carrollton, TX
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Cardiovascular Research Institute of Dallas
mi
from
Dallas, TX
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Cardiovascular Research Institute of Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
North Texas Health Center
mi
from
Dallas, TX
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
North Texas Health Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
The Heart Center of Dallas
mi
from
Dallas, TX
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
The Heart Center of Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Global Medical Research
mi
from
DeSoto, TX
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Global Medical Research
mi
from
DeSoto, TX
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
The Medical Group of Texas
mi
from
Fort Worth, TX
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
The Medical Group of Texas
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Texas Health Physicians Group
mi
from
Fort Worth, TX
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Texas Health Physicians Group
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
T&R Clinic, P.A.
mi
from
Haltom City, TX
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
T&R Clinic, P.A.
mi
from
Haltom City, TX
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Michele P. Sartori, MD
mi
from
Houston, TX
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Michele P. Sartori, MD
mi
from
Houston, TX
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
TEAM Research of Central Texas
mi
from
Killeen, TX
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
TEAM Research of Central Texas
mi
from
Killeen, TX
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Grace Research, LLC
mi
from
Marshall, TX
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Grace Research, LLC
mi
from
Marshall, TX
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Valley Heart Consultants
mi
from
McAllen, TX
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Valley Heart Consultants
mi
from
McAllen, TX
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Heart Center, Palo Pinto General Hospital
mi
from
Mineral Wells, TX
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Heart Center, Palo Pinto General Hospital
mi
from
Mineral Wells, TX
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Valley Central Research Inc
mi
from
Mission, TX
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Valley Central Research Inc
mi
from
Mission, TX
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Grace Research, LLC
mi
from
Palestine, TX
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Grace Research, LLC
mi
from
Palestine, TX
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Schnitzler Cardiovascular Consultants
mi
from
San Antonio, TX
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Schnitzler Cardiovascular Consultants
mi
from
San Antonio, TX
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
San Antonio Endovascular and Heart Institute
mi
from
San Antonio, TX
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
San Antonio Endovascular and Heart Institute
mi
from
San Antonio, TX
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Northwest Houston Clinical Research
mi
from
Tomball, TX
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Northwest Houston Clinical Research
mi
from
Tomball, TX
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Utah Diabetes Center
mi
from
Salt Lake City, UT
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Utah Diabetes Center
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Hampton Family Practice Research
mi
from
Hampton, VA
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Hampton Family Practice Research
mi
from
Hampton, VA
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Tidewater Physicians Multispecialty Group
mi
from
Hampton, VA
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Tidewater Physicians Multispecialty Group
mi
from
Hampton, VA
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Virginia Cardiovascular Associates
mi
from
Manassas, VA
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Virginia Cardiovascular Associates
mi
from
Manassas, VA
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Manassas Clinical Research Center
mi
from
Manassas, VA
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Manassas Clinical Research Center
mi
from
Manassas, VA
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Tucker Cardiology Associates, P.C.
mi
from
Mechanicsville, VA
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Tucker Cardiology Associates, P.C.
mi
from
Mechanicsville, VA
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Sentara Norfolk General Hospital
mi
from
Norfolk, VA
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Sentara Norfolk General Hospital
mi
from
Norfolk, VA
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Roanoke Heart Institute PLC
mi
from
Roanoke, VA
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Roanoke Heart Institute PLC
mi
from
Roanoke, VA
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Tidewater Physicians Multispecialty Group
mi
from
Yorktown, VA
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Tidewater Physicians Multispecialty Group
mi
from
Yorktown, VA
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Premier Clinical Research
mi
from
Spokane, WA
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Premier Clinical Research
mi
from
Spokane, WA
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Kootenai Heart Clinics
mi
from
Spokane, WA
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Kootenai Heart Clinics
mi
from
Spokane, WA
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Northside Internal Medicine
mi
from
Spokane, WA
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Northside Internal Medicine
mi
from
Spokane, WA
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Northwest Medical Associates, P.S.
mi
from
Vancouver, WA
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Northwest Medical Associates, P.S.
mi
from
Vancouver, WA
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Cardiology Associates of Bellin Health
mi
from
Green Bay, WI
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Cardiology Associates of Bellin Health
mi
from
Green Bay, WI
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Dean Foundation
mi
from
Madison, WI
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Dean Foundation
mi
from
Madison, WI
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
University of Wisconsin
mi
from
Madison, WI
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Marshfield Clinic
mi
from
Marshfield, WI
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Marshfield Clinic
mi
from
Marshfield, WI
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Columbia - St. Mary's
mi
from
Milwaukee, WI
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Columbia - St. Mary's
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Aurora St. Luke's Medical Center
mi
from
Milwaukee, WI
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Aurora St. Luke's Medical Center
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Mount Sinai School of Medicine
mi
from
New York, NY
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Mount Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Vijay - Aurora Denver Cardiology
mi
from
Denver, CO
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Vijay - Aurora Denver Cardiology
mi
from
Denver, CO
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Unrein - Rocky Vista University Health Center
mi
from
Parker, CO
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Unrein - Rocky Vista University Health Center
mi
from
Parker, CO
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Pianko - Aventura Research Center, LLC
mi
from
Aventura, FL
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Pianko - Aventura Research Center, LLC
mi
from
Aventura, FL
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Segui - Med Care Research
mi
from
Miami, FL
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Segui - Med Care Research
mi
from
Miami, FL
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Sandoval - Broward Research Center
mi
from
Pembroke Pines, FL
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Sandoval - Broward Research Center
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Gupta - Premier Heart and Vascular Center
mi
from
Wesley Chapel, FL
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Gupta - Premier Heart and Vascular Center
mi
from
Wesley Chapel, FL
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Stahl - Midwest Heart & Vascular Specialists
mi
from
Overland Park, KA
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Stahl - Midwest Heart & Vascular Specialists
mi
from
Overland Park, KA
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Stoddard - University of Louisville
mi
from
Louisville, KY
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Stoddard - University of Louisville
mi
from
Louisville, KY
Click here to add this to my saved trials